Cherdkiat Sangkam, MD
Cardiovascular Disease · Crown Point, INNPI 1174505218
Payments from drug & device makers
Across 35 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$107
- Pfizer$101
- Sanofi-aventis U.S. LLC$77
- Boehringer Ingelheim$64
- Edwards Lifesciences$49
- Novartis$40
- plus $139 from 8 others
What the payments were for
- Food & beverage$577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $107 |
| Pfizer | 5 | $101 |
| Sanofi-aventis U.S. LLC | 5 | $77 |
| Boehringer Ingelheim | 3 | $64 |
| Edwards Lifesciences | 2 | $49 |
| Novartis | 3 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $30 |
| Chiesi USA, Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$577 in reported general payments places this provider in the 25th percentile of 408 cardiovascular disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 33 | $344 |
| ClopidogrelClopidogrel Bisulfate | 16 | $239 |
| Losartan Potassium | 20 | $190 |
| Atorvastatin Calcium | 21 | $179 |
| Potassium Chloride | 12 | $168 |
| Amlodipine Besylate | 39 | $158 |
| Furosemide | 23 | $118 |
| Lisinopril | 11 | $42 |
| Hydrochlorothiazide | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Crown Point
- Manoj DuggalCrown Point$181K
- John McGintyRichmond$3.7M
- Steven SteinhublLafayette$2.4M
- Ravi BhagwatMunster$2.2M
- Mohan KesaniMunster$1.2M
- Vijay MehtaElkhart$925K
- William CollisFort Wayne$842K
- Atul ChughIndianapolis$775K
- Noel DasguptaIndianapolis$744K
- Wail AsfourMunster$736K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.